Clinical Evidence behind Stereotactic Radiotherapy for the Treatment of Ventricular Tachycardia (STAR)-A Comprehensive Review
- PMID: 33802802
- PMCID: PMC8002399
- DOI: 10.3390/jcm10061238
Clinical Evidence behind Stereotactic Radiotherapy for the Treatment of Ventricular Tachycardia (STAR)-A Comprehensive Review
Abstract
The electrophysiology-guided noninvasive cardiac radioablation, also known as STAR (stereotactic arrhythmia radioablation) is an emerging treatment method for persistent ventricular tachycardia. Since its first application in 2012 in Stanford Cancer Institute, and a year later in University Hospital Ostrava, Czech Republic, the authors from all around the world have published case reports and case series, and several prospective trials were established. In this article, we would like to discuss the available clinical evidence, analyze the potentially clinically relevant differences in methodology, and address some of the unique challenges that come with this treatment method.
Keywords: ablation; noninvasive; radiosurgery; stereotactic body radiation therapy; substrate ablation; ventricular tachycardia.
Conflict of interest statement
The authors of this manuscript declare authorship and participation in a noncommercial prospective clinical trial SMART-VT (NCT04642963), and European consortium STOSTORM, which has recently obtained a grant from the Horizon2020 framework.
Figures



Similar articles
-
Stereotactic arrhythmia radioablation: A novel therapy for cardiac arrhythmia.Heart Rhythm. 2023 Sep;20(9):1327-1336. doi: 10.1016/j.hrthm.2023.04.052. Epub 2023 May 5. Heart Rhythm. 2023. PMID: 37150313 Review.
-
Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia.Circulation. 2019 Jan 15;139(3):313-321. doi: 10.1161/CIRCULATIONAHA.118.038261. Circulation. 2019. PMID: 30586734 Free PMC article. Clinical Trial.
-
[Refractory ventricular tachycardia: Is there a role for radiotherapy?].Cancer Radiother. 2020 Oct;24(6-7):534-546. doi: 10.1016/j.canrad.2020.06.005. Epub 2020 Aug 10. Cancer Radiother. 2020. PMID: 32792297 Review. French.
-
Stereotactic arrhythmia radioablation for ventricular tachycardia: a review of clinical trials and emerging roles of imaging.J Radiat Res. 2025 Jan 22;66(1):1-9. doi: 10.1093/jrr/rrae090. J Radiat Res. 2025. PMID: 39656944 Free PMC article. Review.
-
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe.Europace. 2023 Apr 15;25(4):1284-1295. doi: 10.1093/europace/euac238. Europace. 2023. PMID: 36879464 Free PMC article. Review.
Cited by
-
Radiosurgery in Treatment of Ventricular Tachycardia - Initial Experience Within the Polish SMART-VT Trial.Front Cardiovasc Med. 2022 Apr 18;9:874661. doi: 10.3389/fcvm.2022.874661. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35509272 Free PMC article.
-
Case Report: Treatment Planning Study to Demonstrate Feasibility of Transthoracic Ultrasound Guidance to Facilitate Ventricular Tachycardia Ablation With Protons.Front Cardiovasc Med. 2022 May 4;9:849247. doi: 10.3389/fcvm.2022.849247. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35600462 Free PMC article.
-
Implementing stereotactic arrhythmia radioablation with STOPSTORM.eu consortium support: intermediate results of a prospective Israeli single-institutional trial.Strahlenther Onkol. 2025 Feb;201(2):126-134. doi: 10.1007/s00066-024-02300-z. Epub 2024 Sep 16. Strahlenther Onkol. 2025. PMID: 39283343 Free PMC article. Clinical Trial.
-
Letter on 'linear accelerator-based stereotactic arrhythmia radioablation for paroxysmal atrial fibrillation in elderly: a prospective phase II trial'.Europace. 2024 Jun 3;26(6):euae138. doi: 10.1093/europace/euae138. Europace. 2024. PMID: 38818972 Free PMC article. No abstract available.
-
Long-Term Results of the First Clinical Application of Stereotactic Radioablation Using a Linear Electron Accelerator for the Treatment of Ventricular Tachycardia.Bull Exp Biol Med. 2023 Mar;174(5):594-600. doi: 10.1007/s10517-023-05753-x. Epub 2023 Apr 13. Bull Exp Biol Med. 2023. PMID: 37052858
References
-
- Al-Khatib S.M., Stevenson W.G., Ackerman M.J., Bryant W.J., Callans D.J., Curtis A.B., Deal B.J., Dickfeld T., Field M.E., Fonarow G.C., et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A report of the american college of cardiology/american heart association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm. 2018;15:e190–e252. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical